InMode (INMD) Change in Account Payables (2018 - 2026)
InMode (INMD) posted quarterly Change in Account Payables of -$1.1 million for Q1 2026, down 183.39% year-on-year from $1.3 million in Q1 2025, and down 189.14% on a QoQ basis from $1.2 million in Q4 2025.
InMode (INMD) Change in Account Payables (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Change in Account Payables for 9 consecutive years, with -$1.1 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Account Payables fell 183.39% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 1.59% YoY) and the FY2025 annual result came in at $4.1 million, up 2344.02% from the prior year.
- Change in Account Payables fell to -$1.1 million in Q1 2026 per INMD's latest filing, from $1.2 million in the prior quarter.
- Over the last five years, Change in Account Payables for INMD reached as high as $2.9 million in Q4 2022 and fell as low as -$4.3 million in Q1 2023.
- A 5-year average of $474882.4 and a median of $1.2 million in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 2905.71% — and 2023, when it slumped 658.4%.
- Year by year, Change in Account Payables stood at $2.9 million in 2022, then plunged by 44.57% to $1.6 million in 2023, then slumped by 132.52% to -$531000.0 in 2024, then surged by 323.73% to $1.2 million in 2025, then sank by 189.14% to -$1.1 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$1.1 million, $1.2 million, and -$759000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InMode | 956,721.10 | -479.17 Mn | 61.55 Mn | -1.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.06 Mn |
| Mar 31, 2026 | -1.06 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Dec 31, 2025 | 1.19 Mn |
| Sep 30, 2025 | -759,000.00 |
| Sep 30, 2025 | -759,000.00 |
| Jun 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | 2.43 Mn |
| Mar 31, 2025 | 1.27 Mn |
| Mar 31, 2025 | 1.27 Mn |
| Dec 31, 2024 | -531,000.00 |
| Dec 31, 2024 | -531,000.00 |
| Sep 30, 2024 | -1.24 Mn |
| Sep 30, 2024 | -1.24 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | -743,000.00 |
| Mar 31, 2024 | -743,000.00 |
| Dec 31, 2023 | 1.63 Mn |
| Dec 31, 2023 | 1.63 Mn |